In silico single cell dynamics of hepatitis B virus infection and clearance

Journal of Theoretical Biology

Volumn 366, Issue , 2015, Pages 91-102

  Murray, John M ^a   Goyal, Ashish ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

CccDNA loss; Cytolytic response; Hepatocyte turnover; Non cytolytic response; Refractory cells

Indexed keywords

CIRCULAR DNA; COVALENTLY CLOSED CIRCULAR DNA; UNCLASSIFIED DRUG; ANTIVIRUS AGENT; VIRUS DNA;

CELL ORGANELLE; DISEASE INCIDENCE; HEPATITIS; IMMUNITY; INFECTIOUS DISEASE; THEORETICAL STUDY; VIRAL DISEASE;

ARTICLE; CELL DIVISION; CELL PROLIFERATION; CELLULAR PARAMETERS; COMPUTER MODEL; CONTROLLED STUDY; CYTOLYTIC HEPATITIS; CYTOTOXIC T LYMPHOCYTE; HEPATITIS B; HEPATITIS B VIRUS; HEPATOCYTE TURNOVER; INTRACELLULAR MEMBRANE; LIVER CELL; NONHUMAN; VIRAL CLEARANCE; VIREMIA; VIRUS MORPHOLOGY; ACUTE DISEASE; ADAPTIVE IMMUNITY; ANIMAL; COMPUTER SIMULATION; CYTOTOXICITY; GENETICS; HEPATITIS B, CHRONIC; HUMAN; IMMUNOLOGY; INTRACELLULAR SPACE; PATHOGENICITY; PATHOLOGY; PHYSIOLOGY; VIRION; VIROLOGY; VIRUS REPLICATION;

HEPATITIS B VIRUS;

ACUTE DISEASE; ADAPTIVE IMMUNITY; ANIMALS; ANTIVIRAL AGENTS; CELL PROLIFERATION; COMPUTER SIMULATION; CYTOTOXICITY, IMMUNOLOGIC; DNA, CIRCULAR; DNA, VIRAL; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HEPATOCYTES; HUMANS; INTRACELLULAR SPACE; VIREMIA; VIRION; VIRUS REPLICATION;

EID: 84916912020     PISSN: 00225193     EISSN: 10958541     Source Type: Journal    
DOI: 10.1016/j.jtbi.2014.11.020     Document Type: Article

References (45)

1. Andersson H.A., Singh R.A., Barry M.A. Activation of refractory T cell responses against hepatitis C virus core protein by ablation of interfering hydrophobic domains. Mol. Ther. 2006, 13:338-346. 10.1016/j.ymthe.2005.09.005.
2. Belloni L., Allweiss L., Guerrieri F., Pediconi N., Volz T., Pollicino T., Petersen J., Raimondo G., Dandri M., Levrero M. IFN-alpha inhibits HBV transcription and replication in cell culture and in humanized mice by targeting the epigenetic regulation of the nuclear cccDNA minichromosome. J. Clin. Invest. 2012, 122:529-537. 10.1172/jci58847.
3. Bertoletti A., Gehring A.J. The immune response during hepatitis B virus infection. J. Gen. Virol. 2006, 87:1439-1449. 10.1099/vir.0.81920-0.
4. Bertoletti A., Gehring A.J. Immune Therapeutic Strategies in Chronic Hepatitis B Virus Infection: virus or Inflammation Control. PLoS. Pathog. 2013, 9:e1003784. 10.1371/journal.ppat.1003784.
5. Changjiang, L., Huan, Q., 2009. Modeling viral and immune system dynamics of HBV infection. In: Proceedings of the International Conference on Information Engineering and Computer Science, 2009. ICIECS 2009, pp. 1-4.
6. Chisari F.V. Rous-Whipple award lecture. viruses, immunity, and cancer: lessons from hepatitis B. Am. J. Pathol. 2000, 156:1117-1132.
7. Chong C.L., Chen M.L., Wu Y.C., Tsai K.N., Huang C.C., Hu C.P., Jeng K.S., Chou Y.C., Chang C. Dynamics of HBV cccDNA expression and transcription in different cell growth phase. J. Biomed. Sci. 2011, 18:96. 10.1186/1423-0127-18-96.
8. Ciupe S.M., Ribeiro R.M., Nelson P.W., Dusheiko G., Perelson A.S. The role of cells refractory to productive infection in acute hepatitis B viral dynamics. Proc. Natl. Acad. Sci. USA 2007, 104:5050-5055. 10.1073/pnas.0603626104.
9. Dandri M., Burda M.R., Will H., Petersen J. Increased hepatocyte turnover and inhibition of woodchuck hepatitis B virus replication by adefovir in vitro do not lead to reduction of the closed circular DNA. Hepatology 2000, 32:139-146. 10.1053/jhep.2000.8701.
10. Dandri M., Murray J.M., Lutgehetmann M., Volz T., Lohse A.W., Petersen J. Virion half-life in chronic hepatitis B infection is strongly correlated with levels of viremia. Hepatology 2008, 48:1079-1086. 10.1002/hep.22469.
11. De Sousa B.C., Cunha C. Development of mathematical models for the analysis of hepatitis delta virus viral dynamics. PLoS One 2010, 5. 10.1371/journal.pone.0012512.
12. Fu L., Cheng Y.C. Characterization of novel human hepatoma cell lines with stable hepatitis B virus secretion for evaluating new compounds against lamivudine- and penciclovir-resistant virus. Antimicrob. Agents Chemother. 2000, 44:3402-3407.
13. Funk A., Hohenberg H., Mhamdi M., Will H., Sirma H. Spread of hepatitis B viruses in vitro requires extracellular progeny and may be codetermined by polarized egress. J. Virol. 2004, 78:3977-3983.
14. Guo J.T., Pryce M., Wang X., Barrasa M.I., Hu J., Seeger C. Conditional replication of duck hepatitis B virus in hepatoma cells. J. Virol. 2003, 77:1885-1893.
15. Hantz O., Parent R., Durantel D., Gripon P., Guguen-Guillouzo C., Zoulim F. Persistence of the hepatitis B virus covalently closed circular DNA in HepaRG human hepatocyte-like cells. J. Gen. Virol. 2009, 90:127-135. 10.1099/vir.0.004861-0.
16. Kramer I. Modeling the dynamical impact of HIV on the immune system: viral clearance, infection, and AIDS. Math. Comput. Model. 1999, 29:95-112. 10.1016/S0895-7177(99)00057-6.
17. Kock J., Baumert T.F., Delaney W.E.t., Blum H.E., von Weizsacker F. Inhibitory effect of adefovir and lamivudine on the initiation of hepatitis B virus infection in primary tupaia hepatocytes. Hepatology 2003, 38:1410-1418. 10.1016/j.hep.2003.09.009.
18. Kock J., Rosler C., Zhang J.J., Blum H.E., Nassal M., Thoma C. Generation of covalently closed circular DNA of hepatitis B viruses via intracellular recycling is regulated in a virus specific manner. PLoS Pathog. 2010, 6:e1001082. 10.1371/journal.ppat.1001082.
19. Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J. Viral. Hepat. 2004, 11:97-107.
20. Litwin S., Toll E., Jilbert A.R., Mason W.S. The competing roles of virus replication and hepatocyte death rates in the emergence of drug-resistant mutants: theoretical considerations. J. Clin. Virol. 2005, 34(Suppl. 1):S96-S107.
21. Liu J., Zhang E., Ma Z., Wu W., Kosinska A., Zhang X., Moller I., Seiz P., Glebe D., Wang B., Yang D., Lu M., Roggendorf M. Enhancing virus-specific immunity in vivo by combining therapeutic vaccination and PD-L1 blockade in chronic hepadnaviral infection. PLoS Pathog. 2014, 10:e1003856. 10.1371/journal.ppat.1003856.
22. Long C., Qi H., Huang S.H. Mathematical modeling of cytotoxic lymphocyte-mediated immune response to hepatitis B virus infection. J. Biomed. Biotechnol. 2008, 2008:743690. 10.1155/2008/743690.
23. Lucifora J., Xia Y., Reisinger F., Zhang K., Stadler D., Cheng X., Sprinzl M.F., Koppensteiner H., Makowska Z., Volz T., Remouchamps C., Chou W.-M., Thasler W.E., Hüser N., Durantel D., Liang T.J., Münk C., Heim M.H., Browning J.L., Dejardin E., Dandri M., Schindler M., Heikenwalder M., Protzer U. Specific and nonhepatotoxic degradation of nuclear Hepatitis B virus cccDNA. Science 2014, 343:1221-1228. 10.1126/science.1243462.
24. Lutgehetmann M., Volz T., Köpke A., Broja T., Tigges E., Lohse A.W., Fuchs E., Murray J.M., Petersen J., Dandri M. In vivo proliferation of hepadnavirus-infected hepatocytes induces loss of covalently closed circular DNA in mice. Hepatology 2010, 52:16-24.
25. Lutgehetmann M., Volz T., Kopke A., Broja T., Tigges E., Lohse A.W., Fuchs E., Murray J.M., Petersen J., Dandri M. In vivo proliferation of hepadnavirus-infected hepatocytes induces loss of covalently closed circular DNA in mice. Hepatology 2010, 52:16-24. 10.1002/hep.23611.
26. Lutgehetmann M., Mancke L.V., Volz T., Helbig M., Allweiss L., Bornscheuer T., Pollok J.M., Lohse A.W., Petersen J., Urban S., Dandri M. Humanized chimeric uPA mouse model for the study of hepatitis B and D virus interactions and preclinical drug evaluation. Hepatology 2012, 55:685-694. 10.1002/hep.24758.
27. Mason W.S., Litwin S., Xu C., Jilbert A.R. Hepatocyte turnover in transient and chronic hepadnavirus infections. J. Viral Hepat. 2007, 14(Suppl. 1):S22-S28. 10.1111/j.1365-2893.2007.00911.x.
28. Mason W.S., Xu C., Low H.C., Saputelli J., Aldrich C.E., Scougall C., Grosse A., Colonno R., Litwin S., Jilbert A.R. The amount of hepatocyte turnover that occurred during resolution of transient hepadnavirus infections was lower when virus replication was inhibited with entecavir. J. Virol. 2009, 83:1778-1789. 10.1128/jvi.01587-08.
29. Murray J.M., Purcell R.H., Wieland S.F. The half-life of hepatitis B virions. Hepatology 2006, 44:1117-1121. 10.1002/hep.21364.
30. Murray J.M., Wieland S.F., Purcell R.H., Chisari F.V. Dynamics of hepatitis B virus clearance in chimpanzees. Proc. Natl. Acad. Sci. USA 2005, 102:17780-17785. 10.1073/pnas.0508913102.
31. Petersen J., Dandri M., Mier W., Lutgehetmann M., Volz T., von Weizsacker F., Haberkorn U., Fischer L., Pollok J.M., Erbes B., Seitz S., Urban S. Prevention of hepatitis B virus infection in vivo by entry inhibitors derived from the large envelope protein. Nat. Biotechnol. 2008, 26:335-341. 10.1038/nbt1389.
32. Shepard C.W., Simard E.P., Finelli L., Fiore A.E., Bell B.P. Hepatitis B virus infection: epidemiology and vaccination. Epidemiol. Rev. 2006, 28:112-125. 10.1093/epirev/mxj009.
33. Summers J., Smith P.M., Horwich A.L. Hepadnavirus envelope proteins regulate covalently closed circular DNA amplification. J. Virol. 1990, 64:2819-2824.
34. Summers J., Smith P.M., Huang M.J., Yu M.S. Morphogenetic and regulatory effects of mutations in the envelope proteins of an avian hepadnavirus. J. Virol. 1991, 65:1310-1317.
35. Summers J., Jilbert A.R., Yang W., Aldrich C.E., Saputelli J., Litwin S., Toll E., Mason W.S. Hepatocyte turnover during resolution of a transient hepadnaviral infection. Proc. Natl. Acad. Sci. USA 2003, 100:11652-11659. 10.1073/pnas.1635109100.
36. Summers J., Jilbert A.R., Yang W., Aldrich C.E., Saputelli J., Litwin S., Toll E., Mason W.S. Hepatocyte turnover during resolution of a transient hepadnaviral infection. Proc. Natl. Acad. Sci. 2003, 100:11652-11659. 10.1073/pnas.1635109100.
37. Thimme R., Wieland S., Steiger C., Ghrayeb J., Reimann K.A., Purcell R.H., Chisari F.V. CD8(+) T cells mediate viral clearance and disease pathogenesis during acute hepatitis B virus infection. J. Virol. 2003, 77:68-76.
38. Tuttleman J.S., Pourcel C., Summers J. Formation of the pool of covalently closed circular viral DNA in hepadnavirus-infected cells. Cell 1986, 47:451-460.
39. Tuttleman J.S., Pugh J.C., Summers J.W. In vitro experimental infection of primary duck hepatocyte cultures with duck hepatitis B virus. J. Virol. 1986, 58:17-25.
40. Volz T., Lutgehetmann M., Wachtler P., Jacob A., Quaas A., Murray J.M., Dandri M., Petersen J. Impaired intrahepatic hepatitis B virus productivity contributes to low viremia in most HBeAg-negative patients. Gastroenterology 2007, 133:843-852. 10.1053/j.gastro.2007.06.057.
41. Webster G.J., Bertoletti A. Control or persistence of hepatitis B virus: the critical role of initial host-virus interactions. Immunol. Cell Biol. 2002, 80:101-105. 10.1046/j.1440-1711.2002.01060.x.
42. Wieland S.F., Guidotti L.G., Chisari F.V. Intrahepatic induction of alpha/beta interferon eliminates viral RNA-containing capsids in hepatitis B virus transgenic mice. J. Virol. 2000, 74:4165-4173.
43. Wieland S.F., Spangenberg H.C., Thimme R., Purcell R.H., Chisari F.V. Expansion and contraction of the hepatitis B virus transcriptional template in infected chimpanzees. Proc. Natl. Acad. Sci. USA 2004, 101:2129-2134. 10.1073/pnas.0308478100.
44. Yousfi N., Hattaf K., Tridane A. Modeling the adaptive immune response in HBV infection. J. Math. Biol. 2011, 63:933-957. 10.1007/s00285-010-0397-x.
45. Zhang Y.Y., Zhang B.H., Theele D., Litwin S., Toll E., Summers J. Single-cell analysis of covalently closed circular DNA copy numbers in a hepadnavirus-infected liver. Proc. Natl. Acad. Sci. USA 2003, 100:12372-12377. 10.1073/pnas.2033898100.